Botulinum toxin type A in pregnancy

Clicks: 274
ID: 261736
2013
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Botulinum toxin is not expected to be present in systemic circulation following proper intramuscular or intradermal injection. Moreover, BTX-A, which has a high molecular weight, does not appear to cross the placenta. From the 38 pregnancies reported in the literature, including women who had botuli …
Reference Key
m2013canadianbotulinum Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tan M;Kim E;Koren G;Bozzo P;;
Journal canadian family physician medecin de famille canadien
Year 2013
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/24235190
Keywords
injections National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine pregnancy female intramuscular maternal-fetal exchange* botulinum toxins pmid:24235190 pmc3828093 michael tan eunji kim pina bozzo type a / adverse effects* type a / metabolism intradermal neuromuscular agents / adverse effects* neuromuscular agents / metabolism prenatal exposure delayed effects / prevention & control* skin aging

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.